The 20 Best Bone Tumor Doctors Near Me in Vienna, 9

Felasfa Wodajo is an Orthopedics provider practicing medicine in Fairfax, Virginia. Dr. Wodajo is rated as a Distinguished provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Bone Tumor, Ewing Sarcoma, Hemangiopericytoma, Osteochondroma, and Hip Replacement.

Dipti Patel is a Hematologist and an Oncologist practicing medicine in Fairfax, Virginia. Dr. Patel is rated as a Distinguished provider by MediFind in the treatment of Bone Tumor. She is also highly rated in 79 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Hodgkin Lymphoma, Chronic B-Cell Leukemia (CBCL), Bone Marrow Aspiration, and Bone Marrow Transplant.

Timothy Mccarthy is a Hematologist and an Oncologist practicing medicine in Fairfax, Virginia. Dr. Mccarthy is rated as a Distinguished provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 78 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Monoclonal Gammopathy of Undetermined Significance (MGUS).

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Pishvaian is board certified in American Board Of Internal Medicine.

Christina Brzezniak is a Hematologist and an Oncologist practicing medicine in Reston, Virginia. Dr. Brzezniak is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses HER-2 Positive Breast Cancer, Myeloproliferative Neoplasms (MPN), Lung Cancer, and Paget Disease of the Breast.

Alexander Spira is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Spira is rated as a Distinguished provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 96 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Tissue Biopsy.

Harold Agbahiwe is a Radiation Oncologist practicing medicine in Fairfax, Virginia. Dr. Agbahiwe is rated as a Distinguished provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Bone Tumor, Metastatic Brain Tumor, and Primitive Neuroectodermal Tumor (PNET).

Dr. Sekwon Jang is a specialty care physician board certified in internal medicine, hematology, and medical oncology. He has a special interest in management of melanoma and other skin cancers including cutaneous lymphoma. Dr. Jang serves as Director of Melanoma and Cutaneous Oncology Therapeutics and Research and Director of Quality at the Inova Schar Cancer Institute. Before joining Inova, Dr. Jang served as Assistant Professor of Medicine at Georgetown University School of Medicine and Co-Chair of melanoma research group at MedStar Georgetown Cancer Network. Dr. Jang believes in a covenant relationship with his patients, and his goal is to provide the best quality patient-centered care in the setting of multidisciplinary collaboration. Dr. Jang is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, and Eccrine Porocarcinoma.

Brandi Page, M.D., is an assistant professor of radiation oncology and molecular sciences for Johns Hopkins Radiation Oncology Department at Suburban Hospital and a radiation oncologist at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Page has expertise in treating all types of cancer and, for the last several years, has become a highly sought-after specialist in the National Capitol Region (NCR-MD/DC/VA) for her expertise in treating head and neck and brain/central nervous system tumors. In Dr. Page's role with Johns Hopkins she has brought new complex radiotherapy services to the facility and facilitated the team building environment for collaborating practitioners and caregivers in the region. Dr. Page also serves on the Cancer Committee for Sibley and Suburban Hospitals for the American Cancer Society, which brings together multidisciplinary care providers to collaborate on initiatives for continued excellence. She is a teaching faculty member at the Johns Hopkins School of Medicine for medical students, residents and fellows, is the current director of radiation oncology fellowships, initiating and growing the first radiation oncology fellowship at the institution a year after the initiation of the proton center. Dr. Page earned her medical degree at Albany Medical College, completed residency in radiation oncology at the Huntsman Cancer Institute at the University of Utah, and fellowship in translational radiation oncology at Wake Forest University Medical Center, where she earned the Service Excellence in Patient Care Award. At Johns Hopkins she has won awards for clinical excellence nominated by peers many years in a row and a Faculty of the Year award for her teaching efforts. Dr. Page is a member of the American Society of Therapeutic Radiation Oncology, a diplomate of the American Board of Radiology, and a Fellow of the American College of Radiation Oncology. Dr. Page has served on the Board of Directors for Radiating Hope and currently serves on the Board of Directors for Courage Unmasked/911-4-HNC (a Head and Neck Cancer support organization). Dr. Page frequently serves as a sought after reviewer for peer reviewed articles and has served as the Continuing Medical Education Editor for the International Journal of Radiation Oncology Biology Physics (IJROBP). Dr. Page believes the best way to empower patients is with knowledge and partnership and she looks forward to partnering with patients in treating their condition, and helping them successfully get through their treatment and maximize opportunities for a happy healthy life after treatment. Make A Gift LinkedIn https://www.linkedin.com/in/brandi-page-968650b0. Dr. Page is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Brain Tumor, Throat Cancer, Laryngeal Cancer, Glioma, and Gamma Knife Radiosurgery. Dr. Page is board certified in American Board Of Radiology.

Dr. Stephen C. Greco is a radiation oncologist at Sibley Memorial Hospital and the director of the department of radiation oncology at Suburban Hospital. Dr. Greco practices out of Sibley’s Prostate Cancer Multidisciplinary Clinic in Washington, D.C. and Suburban Hospital in Bethesda, MD. Dr. Greco has an expertise in various kinds of cancer, including lung, liver, pancreatic and prostate. He has clinical interests in conformal radiation treatment techniques and prostate cancer treatment, including prostate seed implantation. Dr. Greco earned his undergraduate degree from the University of Virginia and his medical degree from Louisiana State University School of Medicine, where he also completed an internship in internal medicine. Dr. Greco completed his residency in radiation oncology at Baylor College of Medicine. Dr. Greco has been named a Top MD by Consumers’ Checkbook Magazine and was named one of the Top Doctors in the Washington D.C., Baltimore and Washington-Baltimore areas by Castle Connolly in 2012. He is a member of the American Society of Clinical Oncology. Dr. Greco has been involved with a clinical trial for “Radiation and Androgen Ablation for Prostate Cancer.” Dr. Greco was also named the 2015 Best Consulting Physician at Suburban Hospital by Johns Hopkins Medicine Clinical Awards for Physicians and Care Teams. Make A Gift Videos 2015 Best Consulting Physician at Suburban Hospital - Stephen Greco, M.D. Dr. Greco is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Prostatectomy. Dr. Greco is board certified in American Board Of Radiology.

Mark Goldstein is a Hematologist Oncology provider practicing medicine in Bethesda, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma. Dr. Goldstein is board certified in American Board Of Internal Medicine.

Sandesh Rao, M.D., is an orthopaedic surgeon specializing in hip and knee care, with advanced expertise in joint reconstruction and replacement. He offers a full spectrum of treatments, from nonoperative management to minimally invasive hip and knee replacements, partial knee replacement, outpatient joint replacement, and robotic-assisted procedures. Dr. Rao also has specialized training in complex and revision joint replacements including management of periprosthetic fractures and prosthetic joint infections. He utilizes multiple approaches to hip replacement surgery —including direct anterior, anterolateral, direct lateral, and posterolateral. The ultimate goal is to collaborate with patients to deliver care that is personalized, holistic and patient-centered. A native of the D.C. area, Dr. Rao earned his medical degree from Johns Hopkins School of Medicine. He completed an internal medicine residency at the Johns Hopkins Hospital Osler Medical Residency Program, becoming board-certified in internal medicine before pursuing orthopaedic surgery. He went on to complete his orthopaedic surgery residency at Johns Hopkins Hospital and fellowship training in adult reconstruction at Rush University in Chicago. Dr. Rao is an active member of the American Academy of Orthopaedic Surgeons, the Maryland Orthopaedic Association, and the American Association of Hip and Knee Surgeons. He has authored over 50 publications and presented his research at national meetings. His research interests include identifying strategies to best optimize patients for hip and knee replacement surgery while striving to identify strategies to minimize risk in the process. Outside of work, Dr. Rao enjoys spending time with his family and playing tennis and basketball. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Osteoarthritis, Tendinitis, Kienbock's Disease, Hip Replacement, and Knee Replacement. Dr. Rao is board certified in American Board Of Orthopaedic Surgery.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Paller is board certified in American Board Of Internal Medicine.

Arjun Joshi is a Plastic Surgeon and a Surgical Oncologist practicing medicine in Reston, Virginia. Dr. Joshi is rated as an Experienced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Salivary Duct Stones, Sialadenitis, Laryngeal Cancer, Laryngectomy, and Glossectomy.

Chao Yin is a Hematologist and an Internal Medicine provider practicing medicine in Fairfax, Virginia. Dr. Yin is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, Idiopathic Neutropenia, and Paget Disease of the Breast.

Dr. Daniel Kim is a specialty care physician board certified in radiation oncology at Inova Health System. Dr. Kim graduated top of his class from Amherst College with degrees in neuroscience and music, while becoming a four-time All-American tennis athlete and winning the NCAA men’s tennis championship. He graduated with his MD and MBA, with honors, from Harvard. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Metastatic Brain Tumor, Meningioma, and Prostatectomy.

Mather Director, Radiation Oncology Research Inova Radiation Oncology Inova Schar CancerDr. Avani Rao is a specialty care physician board certified in radiation oncology who serves as the Director of Research, Proton Therapy Fellowship Director and lead physician in pediatric radiation oncology. She joined Radiation Oncology Associates in 2020. Her areas of interest are pediatric, gynecologic, gastrointestinal and breast malignancies.Dr. Rao graduated from Yale University magna cum laude with a bachelor’s degree in molecular, cellular and developmental biology. She completed medical school, her internal medicine internship and her radiation oncology residency at Johns Hopkins School of Medicine. She was nominated to Alpha Omega Alpha during medical school, and during her residency, Dr. Rao served as Chief Resident. She pursued additional fellowship training at the University of Maryland to gain specific expertise in proton therapy. Dr. Rao has received several awards supporting her research and recognizing her clinical excellence and has published more than 40 peer-reviewed publications. Dr. Rao is board certified in radiation oncology. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Endometrial Stromal Sarcoma, Endometrial Cancer, Metastatic Brain Tumor, and Prostate Cancer.

Dr. C. Bryce Johnson is a specialty care physician board certified in radiation oncology. He joined Inova Health System in 2021 and has been practicing since 2017. Prior to joining Inova, Dr. Johnson completed his radiation oncology residency at Memorial Sloan Kettering Cancer Center. Dr. Johnson is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Metastatic Brain Tumor, Pleuropulmonary Blastoma, and Familial Prostate Cancer.

Dr. Amin Benyounes is a board-certified medical oncologist specializing in thoracic cancers and early-phase clinical trials. Before joining Inova, Dr. Benyounes served as an Assistant Professor of Medicine at the University of Maryland School of Medicine in Baltimore. He currently serves as the Director of Phase I/Developmental Therapeutics at Inova Schar Cancer and is the Deputy Director of the Molecular Tumor Board. Dr. Benyounes is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Pleuropulmonary Blastoma.

Dr. Michael J. Eblan is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2016. Prior to joining Radiation Oncology Associates, he completed his internal medicine internship and radiation oncology residency at the University of North Carolina at Chapel Hill. There, he served as chief resident, led quality and safety initiatives to improve patient care, and designed prospective clinical investigations of circulating tumor cells as a novel biomarker for radiation treatment response. During his residency, Dr. Eblan also completed additional training in CyberKnife robotic radiosurgery and earned a Lean Six Sigma Yellow Belt certification. Much of his research has focused on the effects of radiation on normal tissues and the development of nanotherapeutics to improve the efficacy of chemoradiotherapy and immunotherapy at the Carolina Center of Cancer Nanotechnology Excellence. Dr. Eblan is trained in all aspects of radiation oncology and has particular clinical interest in thoracic, gastrointestinal, breast, prostate, brain, head and neck, hematologic, and pediatric malignancies. He is experienced with multiple radiotherapy techniques, including proton beam therapy, volumetric modulated arc therapies, intensity-modulated radiation therapy, stereotactic body radiotherapy, CyberKnife radiosurgery, intraoperative radiotherapy, and prostate and gynecologic brachytherapy, including high-dose-rate brachytherapy. His work has been recognized by the American Society for Radiation Oncology, the American Association for Cancer Research, the Conquer Cancer Foundation and the American Society of Clinical Oncology. Dr. Eblan grew up in Fairfax County and graduated with distinction as an Echols Scholar from the University of Virginia, receiving dual degrees in biology and economics. He then trained at the National Institutes of Health in Bethesda, MD, through a postbaccalaureate Intramural Research Training Award and published numerous research articles on genetic alterations contributing to human disease, including publication in the New England Journal of Medicine. He received his medical degree from the University of Pennsylvania School of Medicine, where he was awarded the Ruth L. Kirschstein National Research Service Award to study cancer biology and proton radiotherapy. Dr. Eblan is rated as an Advanced provider by MediFind in the treatment of Bone Tumor. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Prostate Cancer, and Familial Prostate Cancer.